Winston Kung
2022
In 2022, Winston Kung earned a total compensation of $1.8M as Chief Operating Officer and Chief Financial Officer at PMV Pharmaceuticals, a 6% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $129,838 |
|---|---|
| Option Awards | $1,177,183 |
| Salary | $461,455 |
| Total | $1,768,476 |
Kung received $1.2M in option awards, accounting for 67% of the total pay in 2022.
Kung also received $129.8K in non-equity incentive plan and $461.5K in salary.
Rankings
In 2022, Winston Kung's compensation ranked 1,954th out of 5,760 executives tracked by ExecPay. In other words, Kung earned more than 66.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,954 out of 5,760 | 66th |
Division Manufacturing | 1,041 out of 3,136 | 67th |
Major group Chemicals And Allied Products | 440 out of 1,422 | 69th |
Industry group Drugs | 403 out of 1,323 | 70th |
Industry Pharmaceutical Preparations | 291 out of 969 | 70th |
Source: SEC filing on April 28, 2023.
Kung's colleagues
We found two more compensation records of executives who worked with Winston Kung at PMV Pharmaceuticals in 2022.